In the article by Borow et al, “Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure: A Review of Biological Plausibility and Implementation of Flexible Clinical Trial Design,” which published in the July 19, 2019 issue of the journal (Circ Res. 2019;125:265–281. doi: 10.1161/CIRCRESAHA.119.314951), a correction was needed.
The article has been changed to a CC-BY-NC-ND Open Access license.
The corrected version of this article is available at www.ahajournals.org/doi/10.1161/CIRCRESAHA.119.314951.